Abstract bekijken

Deze abstract is toegekend aan sessie BGS: Belgian Glaucoma Society

Titel	Global risk assessment
Abstract Nr.	110

Doel	To discuss current knowledge of global risk assessment in ocular hypertension. To identify patients at greatest risk for symptomatic vision loss. To identify patients who are most likely to benefit from early treatment.
Methodes	The ophthalmologist treating patients with ocular hypertension is frequently faced with the clinical dilemma of which patients to treat and how vigorous treatment should be.
Resultaten	Risk factors can be identified by history such as age, race, and family history or can be clinically observed by examination such as elevated intraocular pressure, optic nerve head appearance, central corneal thickness, and visual field abnormalities. Validated risk calculators for ocular hypertension are currently available mostly derived from the Ocular Hypertension Treatment Study and European Glaucoma Prevention Study.
Conclusie	Calculation of risk should be accompanied by thorough analysis of risks, benefits, and alternatives for the individual patient.

Auteur 1